21 April 2017 in Medical Physics
1 November 2014 in NeuroImage
Multimodal measurements combining broadband near-infrared spectroscopy (NIRS) and phosphorus magnetic resonance spectroscopy ((31)P MRS) assessed associations between changes in the oxidation state of cerebral mitochondrial cytochrome-c-oxidase (Δ[oxCCO]) and (31)P metabolite peak-area ratios during and after transient cerebral hypoxia-ischemia (HI) in the newborn piglet. Twenty-four piglets (aged<24 h) underwent transient HI (inspired oxygen fraction 9% and bilateral carotid artery occlusion for ~20 min). Whole-brain (31)P MRS and NIRS data were acquired every minute. Inorganic phosphate (Pi)/epp, phosphocreatine (PCr)/epp, and total nucleotide triphosphate (NTP)/epp were measured by (31)P MRS and were plotted against Δ[oxCCO] during HI and recovery (epp=exchangeable phosphate pool=Pi+PCr+2γ-NTP+β-NTP). During HI Δ[oxCCO], PCr/epp and NTP/epp declined and Pi/epp increased. Significant correlations were seen between (31)P ratios and Δ[oxCCO]; during HI a threshold point was identified where the relationship between Δ[oxCCO] and both NTP/epp and Pi/epp changed significantly. Outcome at 48 h related to recovery of Δ[oxCCO] and (31)P ratios 1h post-HI (survived: 1-h NTP/epp 0.22 ± 0.02, Δ[oxCCO] -0.29 ± 0.50 μM; died: 1-h NTP/epp 0.10 ± 0.04, Δ[oxCCO] -2.41 ± 1.48 μM). Both lowered Δ[oxCCO] and NTP/epp 1h post-HI indicated mitochondrial impairment. Animals dying before 48 h had slower recovery of both Δ[oxCCO] and (31)P ratios by 1 h after HI.
14 November 2017 in Medical Physics
Purpose: The purpose of this work is to evaluate the performance of dual‐energy CT (DECT) for determining proton stopping power ratios (SPRs) in an experimental environment and to demonstrate its potential advantages over conventional single‐energy CT (SECT) in clinical conditions.Methods: Water equivalent range (WER) measurements of 12 tissue‐equivalent plastic materials and 12 fresh animal tissue samples are performed in a 195 MeV broad proton beam using the dose extinction method. SECT and DECT scans of the samples are performed with a dual‐source CT scanner (Siemens SOMATOM Definition Flash). The methods of Schneider et al. (1996), Bourque et al. (2014), and Lalonde et al. (2017) are used to predict proton SPR on SECT and DECT images. From predicted SPR values, the WER of the proton beam through the sample is predicted for SECT and DECT using Monte Carlo simulations and compared to the measured WER.Results: For homogeneous tissue‐equivalent plastic materials, results with DECT are consistent with experimental measurements and show a systematic reduction of SPR uncertainty compared to SECT, with root‐mean‐square errors of 1.59% versus 0.61% for SECT and DECT, respectively. Measurements with heterogeneous animal samples show a clear reduction of the bias on range predictions in the presence of bones, with −0.88% for SECT versus −0.58% and −0.14% for both DECT methods. An uncertainty budget allows isolating the effect of CT number conversion to SPR and predicts improvements by DECT over SECT consistently with theoretical predictions, with 0.34% and 0.31% for soft tissues and bones in the experimental setup compared to 0.34% and 1.14% with the theoretical method.Conclusions: The present work uses experimental measurements in a realistic clinical environment to show potential benefits of DECT for proton therapy treatment planning. Our results show clear improvements over SECT in tissue‐equivalent plastic materials and animal tissues. Further work towards using Monte Carlo simulations for treatment planning with DECT data and a more detailed investigation of the uncertainties on I‐value and limitations on the Bragg additivity rule could potentially further enhance the benefits of this imaging technology for proton therapy.
12 July 2018 in Physics in Medicine & Biology
Purpose: Novel imaging modalities estimate patient elemental compositions for particle treatment planning. The mean excitation energy (I-value) is a main contributor to the proton range uncertainty. To minimize their impact on beam range errors and quantify their uncertainties, the currently used I-values proposed in 1982 are revisited. The study aims at proposing a new set of optimized elemental I-values for use with the Bragg additivity rule (BAR) and establishing uncertainties on optimized I-values and the BAR. Methods: We optimize elemental I-values for the use in compounds based on measured material I-values. We gain a new set of elemental I-values and corresponding uncertainties, based on the experimental uncertainties and our uncertainty model. We evaluate uncertainties on I-values and relative stopping powers (RSP) of 70 human tissues, taking into account statistical correlations between tissues and water. The effect of new I-values on proton beam ranges is quantified using Monte Carlo simulations. Results: Our elemental I-values describe measured material I-values with higher accuracy than ICRU-recommended I-values (RMSE: 6.17% (ICRU), 5.19% (this work)). Our uncertainty model estimates an uncertainty component from the BAR to 4.42%. Using our elemental I-values, we calculate the I-value of water as 78.73+/-2.89 eV, being consistent with ICRU 90 (78+/-2 eV). We observe uncertainties on tissue I-values between 1.82-3.38 eV, and RSP uncertainties between 0.002%-0.44%. With transport simulations of a proton beam in human tissues, we observe range uncertainties between 0.31% and 0.47%, as compared to current estimates of 1.5%. Conclusion: We propose a set of elemental I-values well suited for human tissues in combination with the BAR. Our model establishes uncertainties on elemental I-values and the BAR, enabling to quantify uncertainties on tissue I-values, RSP as well as particle range. This work is particularly relevant for Monte Carlo simulations where the interaction probabilities are reconstructed from elemental compositions.
4 September 2017 in Medical Physics
19 August 2015 in Biomedical Physics & Engineering Express
Metal artifacts in computed tomography (CT) images can cause important errors in dose calculation. Algorithms developed to reduce these artifacts could improve these images but also introduce a bias in tissues surrounding metallic implants. The purpose of this study is to validate a pre-commercial metal artifact reduction tool for radiotherapy treatment planning. The performance of the iterative metal artifact reduction (iMAR) algorithm developed by Siemens Healthcare is evaluated on a test platform. A calibration phantom constituted of tissue-equivalent plastics is used to estimate the image bias from artifact correction. Patient CT data with metal implants (seven dental fillings, one bilateral hip) are reconstructed using weighted filtered backprojection and corrected using the iMAR algorithm. Radiotherapy treatment plans are calculated and compared on corrected and uncorrected images using the collapsed cone convolution dose algorithm implemented in RayStation (RaySearch). Phantom scans show that iMAR reproduces CT numbers within ±44 HU for tissue equivalent substitutes in 3.6 cm2 circular ROIs. The effect of this CT number difference on megavoltage photon dose calculation is shown to be within ±1% dose error. Comparing patient plans from corrected and uncorrected images, dose differences of up to ±5% are discovered in target volume and organs at risk, depending on the treatment site. The iMAR algorithm resulted in improvement of image quality in metal artifact affected CT images for radiotherapy planning. The technique reduces dose errors significantly while keeping calculated doses in the surrounding tissues within a clinically acceptable level in comparison to ground truth. Future work could aim at the improvement of benchmark methods for a clinical environment.